Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Combination Therapy With Intravenous Ketorolac and Metoclopramide for Pediatric Migraine Therapy in the Emergency Department

NCT01596166 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT01596166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01596166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Combination Therapy With Intravenous Ketorolac and Metoclopramide for Pediatric Migraine Therapy in the Emergency Department
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2012
Completion date
April 30, 2014
Enrollment
56 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine with aura, migraine without aura, probable migraine